APLM
Apollomics Inc. Class A Ordinary Shares
NASDAQ: APLM · HEALTHCARE · BIOTECHNOLOGY
$13.08
+1.75% today
Updated 2026-04-29
Market cap
$28.71M
P/E ratio
—
P/S ratio
3.19x
EPS (TTM)
$-7.57
Dividend yield
—
52W range
$4 – $40
Volume
0.0M
Apollomics Inc. Class A Ordinary Shares (APLM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-121.60%
Operating margin
329.80%
ROE
-1,305.00%
ROA
-56.70%
Debt/equity
-0.17x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-45.91M | — | — | — |
| 2020 | $1.84M | $-74.82M | 100.00% | -2,211.43% | -4,070.73% |
| 2021 | $2000.00 | $-94.80M | 100.00% | -2,542,850.00% | -4,739,850.00% |
| 2022 | $323000.00 | $-240.81M | 100.00% | -13,956.97% | -74,554.49% |
| 2023 | $821000.00 | $-172.60M | 100.00% | -6,578.93% | -21,023.26% |
| 2024 | $198000.00 | $-53.86M | 100.00% | -21,280.81% | -27,201.01% |
| 2025 | $8.50M | $-10.94M | — | -108.16% | -128.69% |